G/TBT/N/USA/1657  
19 October 2020  
(20-7194) Page: 1/2 
Committee on Technical Barriers to Trade  Original:  English  
 
  
NOTIFICATION  
The following notification is being circulated in accordance with Article 10.6  
 
1. Notifying Member:  UNITED STATES OF AMERICA   
If applicable, name of local government involved (Article 3.2 and 7.2):   
2. Agency responsible:  Food and Drug Administration (FDA), Health and Human Services 
(HHS) [1685]  
Name and address (including telephone and fax numbers , email and website 
addresses, if available) of agency or authority designated to handle comments 
regarding the not ification shall be indicated if different from above:   
Please submit comments to: USA WTO TBT Enquiry Point, Email: usatbtep@nist.gov  
3. Notified under Article 2.9.2 [   ], 2.10.1 [   ], 5.6.2 [   ], 5.7.1 [   ], other  [X]:  
4. Products covered (HS or CCCN where applicable, otherwise national tariff 
heading. ICS numbers may be provided in addition, where applicable):  Foods 
comprised of or containing cultured seafood cells; Processes in the food industry (ICS 
67.020), Food products in general (ICS 67.040), Meat, meat products and other animal 
produce (ICS 67.120)  
5. Title, number of pages and language(s) of the notifi ed document:  Labeling of 
Foods Comprised of or Containing Cultured Seafood Cells; Request for Information (4 
page(s), in English)  
6. Description of content:  Notice and request for information - 
The Food and Drug Administration (FDA or we) is requesting in formation pertaining to the 
labeling of foods comprised of or containing cultured seafood cells. Foods comprised of or 
containing cultured seafood cells are being developed and may soon enter the 
marketplace. Therefore, we intend to use information and dat a resulting from this notice 
to determine what type(s) of action, if any, we should take to ensure that these foods are 
labeled properly.  
7. Objective and rationale, including the nature of urgent problems where 
applicable:  Consumer information, labelling  G/TBT/N/USA/1657  
 
- 2 - 
 
  8. Relevant documents:   
85 Federal Register (FR) 63277, 7 October 2020:  
https://www.govinfo.gov/content/pkg/FR -2020-10-07/ht ml/2020 -22140.htm  
https://www.govinfo.gov/content/pkg/FR -2020-10-07/pdf/2020 -22140.pdf  
This notice and request for information is identified by Docket Number F DA-2020-N-1720. 
The Docket Folder is available on Regulations.gov at 
https://www.regulations.gov/docket?D=FDA -2020-N-1720 and provides access to 
primary documents as well as c omments received. Documents are also accessible from 
Regulations.gov by searching the Docket Number.   WTO Members and their stakeholders 
are asked to submit comments to the USA TBT Enquiry Point .  Comments received by the 
USA TBT Enquiry Point from WTO Members and their stakeholders will be shared with the 
regulator and will also be submitted to the Docket  on Regulations.gov if received within 
the comment period.  
9. Proposed date of adoption:  To be determined  
Proposed date of entry into force:  To be determined  
10. Final date for comments:  8 March 2021  
11. Texts available from:  National enquiry point [ ] or address, telephone and fax 
numbers and email and website addresses, if available , of other body:   
https://members.wto.org/crnattachments/2020/TBT/USA/20_6220_00_e.pdf